search for books and compare prices
cover image
Combined Modality of Central Nervous System Tumors
By M. Bamberg (editor), Luther W. Brady (editor), Zbigniew Petrovich (editor) and Michael L. J. Apuzzo (editor)
Price
Store
Arrives
Preparing
Shipping
The price is the lowest for any condition, which may be new or used; other conditions may also be available.
Jump down to see edition details for: Hardcover
Bibliographic Detail
Publisher Springer Verlag
Publication date September 14, 2000
Pages 640
Binding Hardcover
Book category Adult Non-Fiction
ISBN-13 9783540660538
ISBN-10 3540660534
Dimensions 1.25 by 7.50 by 10.50 in.
Weight 4.25 lbs.
Published in Europe
Original list price $369.00
Other format details medical
Summaries and Reviews
Amazon.com description: Product Description:

The American Cancer Society anticipates that 16,500 patients will be diagnosed with primary malignant tumors of the central nervous system in 2000, with about 200,000 individuals presenting with brain metastases. The advances in the treatment of solid tumors have contributed significantly to the major increase in metastatic cancers to the brain. Of the primary malignant tumors of the brain, more than 50% are high-grade gliomas; the incidence has been increasing among older patients over the past decade. Major developments in new technologies in the treatment of primary brain tumors as well as metastatic disease are covered in depth. Even though management is difficult, advances are being made. This book is a concerted effort to present data regarding basic science research efforts alongside their translation into clinical practice using combined, integrated multimodal programs of treatment. Progress has been made, but innovatice approaches need to be pursued.



Editions
Hardcover
Book cover for 9783540660538
 
The price comparison is for this edition
from Springer Verlag (September 14, 2000)
9783540660538 | details & prices | 640 pages | 7.50 × 10.50 × 1.25 in. | 4.25 lbs | List price $369.00
About: The American Cancer Society anticipates that 16,500 patients will be diagnosed with primary malignant tumors of the central nervous system in 2000, with about 200,000 individuals presenting with brain metastases.

Pricing is shown for items sent to or within the U.S., excluding shipping and tax. Please consult the store to determine exact fees. No warranties are made express or implied about the accuracy, timeliness, merit, or value of the information provided. Information subject to change without notice. isbn.nu is not a bookseller, just an information source.